Related Experiment Video
Updated: Feb 13, 2026

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice
Published on: October 31, 2007
Better Diabetes Diagnoses in Sweden
1Karolinska Institutet - CLINTEC enheten för pediatrik Stockholm, Sweden Karolinska Institutet - CLINTEC enheten för pediatrik Stockholm, Sweden.
Insights
The Better Diabetes Diagnosis study improved differentiating type 1 and type 2 diabetes in children using HLA antibodies and C-peptide tests. Early diagnosis and re-evaluation are crucial for optimal treatment and prognosis.
Area of Science:
- Pediatrics
- Endocrinology
- Immunology
Background:
- The Better Diabetes Diagnosis (BDD) study, a decade-long Swedish initiative, collected data from over 8000 children and adolescents with new-onset diabetes.
- Accurate differentiation between diabetes types in pediatric populations is critical for appropriate management and long-term outcomes.
Purpose of the Study:
- To enhance the diagnostic accuracy for distinguishing type 1 diabetes, type 2 diabetes, and monogenic diabetes (MODY) in children and adolescents.
- To integrate improved diagnostic markers into routine clinical practice for newly diagnosed pediatric diabetes cases.
Main Methods:
- Utilized human leukocyte antigen (HLA) diabetes antibodies and C-peptide level analysis to improve diagnostic discrimination.
- Recommended sequencing of monogenic diabetes (MODY) genes for auto-antibody negative cases with a low type 1 diabetes risk HLA pattern.
Main Results:
- Demonstrated improved discrimination between type 1 and type 2 diabetes through the combined use of HLA antibodies and C-peptide measurements.
- These validated analyses are now standard in the clinical evaluation of all Swedish children and adolescents diagnosed with diabetes.
Conclusions:
- HLA antibodies and C-peptide testing significantly enhance the accuracy of diabetes diagnosis in pediatric patients.
- Early identification of monogenic diabetes (MODY) is essential, warranting genetic sequencing in specific clinical scenarios.
- Despite advancements, a follow-up re-evaluation of the diabetes diagnosis after one year is advisable due to potential initial diagnostic challenges.
Abstract:
The Swedish study Better Diabetes Diagnosis (BDD) has now been ongoing for ten years and detailed information and blood samples have been collected from more than 8000 children and adolescents with newly diagnosed diabetes. We have been able to demonstrate that by means of HLA diabetes antibodies and C-peptide the discrimination between type one and type 2 diabetes is improved. These analyses are therefore included in the clinical check-up for all children and adolescents in Sweden who are diagnosed with diabetes. Type 1 diabetes is by far the most prevalent type of diabetes among Swedish children and adolescents. Type 2 diabetes is still relatively rare in Sweden but it is urgent to obtain a correct diagnosis as the long-term prognosis depends on a prompt pharmacological treatment. Monogenic diabetes (MODY) is also important to identify early. We therefore recommend that sequencing of MODY genes should be performed if an individual with newly-diagnosed diabetes is auto-antibody negative and has an HLA pattern associated with low risk for type 1 diabetes. However, despite these analytical tools it can be difficult to make the correct diabetes diagnosis initially. It is therefore prudent to re-evaluate the diabetes diagnosis after one year.
More Related Videos
16:26Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
Related Concept Videos
Diagnosing Acidosis and Alkalosis
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational